Category: Bayer HealthCare
Women rallying against the Essure contraceptive implant are congregating online and picketing on street corners, calling on Bayer to recall the device.
MASSDEVICE ON CALL — The anti-Essure movement, launched by women who claim the permanent contraceptive implant left them with severe pain and injuries, doesn't look likely to die down, having spawned Facebook support pages, Twitter campaigns and lots of media attention.
The movement has attached itself to the Twitter hashtag '#EssureRally', through which women are calling on Bayer to recall the device, posting pictures of the ralliers in action and organizing real-world events, including street-corner picketing and conference calls with famed consumer advocate Erin Brockovich.
GlobalData analyst Joseph Gregory says public advocate Erin Brockovich's patient safety claims against Bayer's Essure contraceptive implant are "inappropriate" and "unsubstantiated."
Bayer's Contour Next Link blood glucose meter is the 1st U.S.-cleared device that pairs with Medtronic's newly approved 'artificial pancreas', the MiniMed 530G with Enlite diabetes management system.
The FDA says its additional review suggests Bayer's Essure permanent birth control device isn't connected to rising patient reports of post-treatment weight-gain, depression and fatigue.
It looks like healthcare giant Bayer (PINK:BAYRY) has got the FDA in its corner against a rising tide of patient complaints over the company's Essure permanent birth control device.
Real-world consumer advocate Erin Brockovich sets her sights on healthcare giant Bayer's Essure contraceptive implants.
MASSDEVICE ON CALL — Erin Brockovich, the activist made famous by Julia Roberts' portrayal in a 2000 blockbuster film, is taking on healthcare giant Bayer (PINK:BAYRY), saying the company's Essure birth control device has harmed women.
Bayer closes a $1.1 billion offer for Conceptus, hoping to expand its portfolio of contraceptive methods and devices.
Medical device company Conceptus agrees to a $1.1 billion buyout by German healthcare conglomerate Bayer AG.
Conceptus (NSDQ:CPTS) agreed to a buyout by Bayer (PINK:BAYRY) in a deal valued at $1.1 billion.